Rapid Review Quiz: Continuous Glucose Monitoring Devices

Romesh Khardori, MD, PhD


May 31, 2023

In a recent, randomized, open-label study, researchers investigated the effects of using isCGM devices along with structured education about the device to support patient-driven lifestyle modification in patients with type 2 diabetes in a 12-week, open-label, randomized controlled trial. The 126 participants were placed in either the control group (standard care with blood glucose monitoring) or intervention group (structured education + isCGM). The structured education was the Self-Evaluation Of Unhealthy foods by Looking at postprandial glucose (SEOUL) algorithm, intended to assist them in following healthy eating behaviors; the change in A1c level from baseline was the primary endpoint.

The intervention was associated with greater improvement in A1c vs standard care. Participants in the intervention group also had a greater reduction in fasting blood glucose and body weight. The researchers concluded that patient-driven lifestyle modification using isCGM that is focused mainly on eating behavior effectively reduces A1c levels in patients with type 2 diabetes.

Learn more about type 2 diabetes.

This Rapid Review Quiz was excerpted and adapted from the Medscape articles Real-Time CGM Plus Insulin Pump Best for Type 1 Diabetes, Blood Glucose Monitors, Diabetes Mellitus and Pregnancy, Hypoglycemia, and Type 2 Diabetes Mellitus.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.